{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-074558","form_type":"8-K","ticker":"ESPR","cik":"0001434868","company_name":"Esperion Therapeutics, Inc.","filed_at":"2026-06-16T20:00:58+00:00","discovered_at":"2026-06-16T20:02:00.640267+00:00","generated_at":"2026-06-16T20:05:20.141484+00:00","sec_items":["8.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Esperion HSR waiting period cleared for ArchiMed merger; shareholder vote set for July 8","bullets":["Hart-Scott-Rodino waiting period expired June 15, 2026, satisfying a key regulatory condition.","Special stockholder meeting to vote on merger adoption scheduled for July 8, 2026 at 8:00 a.m. ET.","Closing remains subject to other customary conditions, including stockholder approval.","Merger with affiliate of ArchiMed SAS was announced May 1, 2026; transaction is pending."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-074558","json":"https://secwatch.observer/filing/0001104659-26-074558.json","markdown":"https://secwatch.observer/filing/0001104659-26-074558.md","text":"https://secwatch.observer/filing/0001104659-26-074558.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1434868/000110465926074558/0001104659-26-074558-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1434868/000110465926074558/tm2617356d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T20:05:20.141484+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}